ATPase-IN-3

CAS No. 1134203-12-5

ATPase-IN-3( —— )

Catalog No. M37359 CAS No. 1134203-12-5

ATPase-IN-3 is an ATPase (ATPase) inhibitor that can be used in the study of metabolism-related diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 29 In Stock
5MG 42 In Stock
10MG 65 In Stock
25MG 136 In Stock
50MG 206 In Stock
100MG 303 In Stock
200MG 452 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ATPase-IN-3
  • Note
    Research use only, not for human use.
  • Brief Description
    ATPase-IN-3 is an ATPase (ATPase) inhibitor that can be used in the study of metabolism-related diseases.
  • Description
    ATPase-IN-3 is an ATPase (ATPase) inhibitor that can be used in the study of metabolism-related diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    ATPase
  • Recptor
    ATPase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1134203-12-5
  • Formula Weight
    266.3
  • Molecular Formula
    C10H6N2O3S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S=C(NC/1=O)SC1=C/C2=CC([N+]([O-])=O)=CC=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Oligomycin A

    Oligomycin A, created by Streptomyces, acts as a mitochondrial F0F1-ATPase inhibitor, with a Ki of 1 μM.

  • NDI-091143

    NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay)indirectly disrupting citrate binding via an unexpected mechanism of inhibition.

  • AGN-201904

    AGN-201904 is an omeprazole prodrug and proton pump inhibitor, which may delay aging and be used for the prevention and treatment of peptic ulcers.